TRITON and Beyond: New Insights into the Profile of Prasugrel
Joseph A. Jakubowski(Indiana Biosciences Research Institute), David Erlinge(Lund University), Amy G Leishman(Eli Lilly (United States)), Sandra Close(Eli Lilly (United States)), Jeffrey S. Riesmeyer(Eli Lilly (United States))
Cited by 24
Related Papers
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979